|
SDCCAG1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.28200000510037E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.88050000005102E-06 |
| Normal-vs-Stage2 |
5.52750000000213E-05 |
| Normal-vs-Stage3 |
2.76159999978987E-07 |
| Normal-vs-Stage4 |
2.21689999690966E-09 |
| Stage1-vs-Stage2 |
3.476400E-01 |
| Stage1-vs-Stage3 |
6.939600E-02 |
| Stage1-vs-Stage4 |
7.119500E-03 |
| Stage2-vs-Stage3 |
7.231400E-01 |
| Stage2-vs-Stage4 |
1.934250E-01 |
| Stage3-vs-Stage4 |
2.377000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.77509999611215E-08 |
| Normal-vs-AfricanAmerican |
1.298290E-03 |
| Normal-vs-Asian |
4.592900E-04 |
| Caucasian-vs-AfricanAmerican |
9.728600E-01 |
| Caucasian-vs-Asian |
6.877200E-01 |
| AfricanAmerican-vs-Asian |
8.253000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.48720002979275E-09 |
| Normal-vs-Female |
6.78990000002599E-07 |
| Male-vs-Female |
3.025500E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.36999999997578E-06 |
| Normal-vs-Age(41-60Yrs) |
3.74800000035869E-07 |
| Normal-vs-Age(61-80Yrs) |
1.04709999559915E-08 |
| Normal-vs-Age(81-100Yrs) |
9.983600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.037400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.849900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.716600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.363400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.412000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.561600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.175800E-01 |
| Classical-VS-Follicular |
3.762400E-02 |
| Classical-VS-Other |
5.805800E-01 |
| Classical-VS-Normal |
1.52310000001155E-06 |
| Tall-VS-Follicular |
3.783400E-01 |
| Tall-VS-Other |
8.327600E-01 |
| Tall-VS-Normal |
4.241700E-04 |
| Follicular-VS-Other |
8.164600E-01 |
| Follicular-VS-Normal |
1.42599999997106E-06 |
| Other-VS-Normal |
2.688000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.25629999958576E-07 |
| Normal-vs-N1 |
3.94519999999954E-05 |
| N0-vs-N1 |
6.377400E-01 |
|
|
